Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

Abstract:

:Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplant reflects a complex immune response resulting in chronic damage to multiple tissues. Previous studies indicated that donor B cells and the antibodies they produce play an important role in the development of cGVHD. To understand the pathogenic role of antibodies in cGVHD, we focused our studies on posttransplant production of immunoglobulin G antibodies targeting cell surface antigens expressed in multiple cGVHD affected tissues, due to their potential functional impact on living cells in vivo. Using plate-bound cell membrane proteins as targets, we detected a significantly higher level of antibodies reactive with these membrane antigens in patients who developed cGVHD, compared with those who did not and healthy donors. Plasma-reactive antibody levels increased significantly prior to the clinical diagnosis of cGVHD and were reduced following cGVHD therapies including prednisone, interleukin-2, or extracorporeal photophoresis. Using cell-based immunoprecipitation with plasma from cGVHD patients and mass spectrometry, we identified 43 membrane proteins targeted by these antibodies. The presence of antibodies in cGVHD patients' plasma that specifically target 6 of these proteins was validated. Antibodies reactive with these 6 antigens were more frequently detected in patients with cGVHD compared with patients without cGVHD and healthy donors. These results indicate that antibodies that target membrane antigens of living cells frequently develop in cGVHD patients and further support a role for B cells and antibodies in the development of cGVHD.

journal_name

Blood

journal_title

Blood

authors

Wang KS,Kim HT,Nikiforow S,Heubeck AT,Ho VT,Koreth J,Alyea EP,Armand P,Blazar BR,Soiffer RJ,Antin JH,Cutler CS,Ritz J

doi

10.1182/blood-2017-08-801001

subject

Has Abstract

pub_date

2017-12-28 00:00:00

pages

2889-2899

issue

26

eissn

0006-4971

issn

1528-0020

pii

blood-2017-08-801001

journal_volume

130

pub_type

杂志文章

相关文献

BLOOD文献大全
  • CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.

    abstract::The chemokine receptors (CCRs) CCR4 and CCR10, and the cutaneous lymphocyte antigen (CLA), have each been proposed as critical mediators of skin-specific TH lymphocyte homing in mice and humans. CLA initiates skin homing by mediating E-selectin-dependent tethering and rolling within cutaneous venules, but the specific...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2348

    authors: Soler D,Humphreys TL,Spinola SM,Campbell JJ

    更新日期:2003-03-01 00:00:00

  • Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction.

    abstract::Endothelial progenitor cell (EPC) mobilization has been reported following tissue damage, whereas no data are available regarding the mobilization of hematopoietic progenitor cells (HPCs). We performed the phenotypic and functional analysis of circulating CD34+ progenitor cells in patients with acute myocardial infarc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-05-1831

    authors: Massa M,Rosti V,Ferrario M,Campanelli R,Ramajoli I,Rosso R,De Ferrari GM,Ferlini M,Goffredo L,Bertoletti A,Klersy C,Pecci A,Moratti R,Tavazzi L

    更新日期:2005-01-01 00:00:00

  • Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.

    abstract::Myelodysplastic syndromes (MDSs) are chronic and often progressive myeloid neoplasms associated with remarkable heterogeneity in the histomorphology and clinical course. Various somatic mutations are involved in the pathogenesis of MDS. Recently, mutations in a gene encoding a spliceosomal protein, SF3B1, were discove...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-399774

    authors: Makishima H,Visconte V,Sakaguchi H,Jankowska AM,Abu Kar S,Jerez A,Przychodzen B,Bupathi M,Guinta K,Afable MG,Sekeres MA,Padgett RA,Tiu RV,Maciejewski JP

    更新日期:2012-04-05 00:00:00

  • Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation.

    abstract::Interleukin-25 (IL-25) is a recently described T helper 2 (T(H)2) cell-derived cytokine that belongs to the IL-17 family and induces the production of IL-4, IL-5, and IL-13 from an unidentified non-T-cell population. Here, we show that mast cells are also potent IL-25-producing cells. When bone marrow-derived mast cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2817

    authors: Ikeda K,Nakajima H,Suzuki K,Kagami S,Hirose K,Suto A,Saito Y,Iwamoto I

    更新日期:2003-05-01 00:00:00

  • The multifaceted role of fibrinogen in tissue injury and inflammation.

    abstract::The canonical role of the hemostatic and fibrinolytic systems is to maintain vascular integrity. Perturbations in either system can prompt primary pathological end points of hemorrhage or thrombosis with vessel occlusion. However, fibrin(ogen) and proteases controlling its deposition and clearance, including (pro)thro...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-07-818211

    authors: Luyendyk JP,Schoenecker JG,Flick MJ

    更新日期:2019-02-07 00:00:00

  • Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.

    abstract::We investigated whether atorvastatin (AT) was capable of protecting animals from acute graft-versus-host disease (aGVHD) across major histocompatibility complex (MHC) mismatch barriers. AT treatment of the donor induced a Th-2 cytokine profile in the adoptively transferred T cells and reduced their in vivo expansion, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-106005

    authors: Zeiser R,Youssef S,Baker J,Kambham N,Steinman L,Negrin RS

    更新日期:2007-12-15 00:00:00

  • How I treat patients who mobilize hematopoietic stem cells poorly.

    abstract::Transplantation with 2-5 × 10(6) mobilized CD34(+)cells/kg body weight lowers transplantation costs and mortality. Mobilization is most commonly performed with recombinant human G-CSF with or without chemotherapy, but a proportion of patients/donors fail to mobilize sufficient cells. BM disease, prior treatment, and a...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-06-318220

    authors: To LB,Levesque JP,Herbert KE

    更新日期:2011-10-27 00:00:00

  • Distinctive localization of antigen-presenting cells in human lymph nodes.

    abstract::Professional antigen-presenting cells (APCs) are sentinel cells of the immune system that present antigen to T lymphocytes and mediate an appropriate immune response. It is therefore surprising that knowledge of the professional APCs in human lymph nodes is limited. Using 3-color immunohistochemistry, we have identifi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-165266

    authors: Angel CE,Chen CJ,Horlacher OC,Winkler S,John T,Browning J,MacGregor D,Cebon J,Dunbar PR

    更新日期:2009-02-05 00:00:00

  • Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia.

    abstract::The syndrome of episodic angioedema and eosinophilia is characterized by cyclic edema, marked peripheral blood eosinophilia, and eosinophil degranulation in the dermis. Using a sensitive immunoenzymetric method, we measured serum interleukin (IL)-5 levels in four patients with this syndrome. We also determined the per...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Butterfield JH,Leiferman KM,Abrams J,Silver JE,Bower J,Gonchoroff N,Gleich GJ

    更新日期:1992-02-01 00:00:00

  • Sickle cell acute chest syndrome: pathogenesis and rationale for treatment.

    abstract::Acute chest syndrome (ACS) is a leading cause of death in sickle cell disease (SCD). Our previous work showed that hypoxia enhances the ability of sickle erythrocytes to adhere to human microvessel endothelium via interaction between very late activation antigen-4 (VLA4) expressed on sickle erythrocytes and the endoth...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stuart MJ,Setty BN

    更新日期:1999-09-01 00:00:00

  • The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression.

    abstract::Reactivation of fetal hemoglobin remains a critical goal in the treatment of patients with sickle cell disease and β-thalassemia. Previously, we discovered that silencing of the fetal γ-globin gene requires the erythroid-specific eIF2α kinase heme-regulated inhibitor (HRI), suggesting that HRI might present a pharmaco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005301

    authors: Huang P,Peslak SA,Lan X,Khandros E,Yano JA,Sharma M,Keller CA,Giardine B,Qin K,Abdulmalik O,Hardison RC,Shi J,Blobel GA

    更新日期:2020-06-11 00:00:00

  • Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs.

    abstract::Whereas the final differentiation of conventional dendritic cells (CDCs) from committed precursors occurs locally in secondary lymphoid or peripheral tissues, plasmacytoid dendritic cells (PDCs) are thought to fully develop in the bone marrow from common DC progenitors before migrating to the periphery. In our study, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-326678

    authors: Schlitzer A,Loschko J,Mair K,Vogelmann R,Henkel L,Einwächter H,Schiemann M,Niess JH,Reindl W,Krug A

    更新日期:2011-06-16 00:00:00

  • Platelets and platelet-like particles mediate intercellular RNA transfer.

    abstract::The role of platelets in hemostasis and thrombosis is clearly established; however, the mechanisms by which platelets mediate inflammatory and immune pathways are less well understood. Platelets interact and modulate the function of blood and vascular cells by releasing bioactive molecules. Although the platelet is an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-12-396440

    authors: Risitano A,Beaulieu LM,Vitseva O,Freedman JE

    更新日期:2012-06-28 00:00:00

  • Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets.

    abstract::Human platelets are aggregated and induced to release their granule contents and form thromboxane by peptides as short as 6-amino acid residues (SFLLRN) corresponding to the newly released N-terminus of the thrombin receptor that is cleaved by thrombin. Using washed platelets, we found that these responses to SFLLRN (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kinlough-Rathbone RL,Rand ML,Packham MA

    更新日期:1993-07-01 00:00:00

  • Exploiting the kinetic interplay between GPIbα-VWF binding interfaces to regulate hemostasis and thrombosis.

    abstract::Platelet-von Willebrand factor (VWF) interactions must be tightly regulated in order to promote effective hemostasis and prevent occlusive thrombus formation. However, it is unclear what role the inherent properties of the bond formed between the platelet receptor glycoprotein Ibα and the A1 domain of VWF play in thes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-04-569392

    authors: Chen J,Zhou H,Diacovo A,Zheng XL,Emsley J,Diacovo TG

    更新日期:2014-12-11 00:00:00

  • Regulation of growth differentiation factor 15 expression by intracellular iron.

    abstract::Growth differentiation factor 15 (GDF15) is a divergent member of the transforming growth factor-beta superfamily and has been identified in different contexts as a hypoxia-inducible gene product and as a molecule involved in hepcidin regulation. The biology of iron and oxygen is closely related, and known regulatory ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2008-07-170431

    authors: Lakhal S,Talbot NP,Crosby A,Stoepker C,Townsend AR,Robbins PA,Pugh CW,Ratcliffe PJ,Mole DR

    更新日期:2009-02-12 00:00:00

  • Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

    abstract::This phase 2 study evaluated whether substituting bortezomib for vincristine in frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy could improve efficacy in non-germinal center B-cell-like diffuse large B-cell lymphoma (non-GCB DLBCL), centrally confirmed by immunohist...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2015-03-632430

    authors: Offner F,Samoilova O,Osmanov E,Eom HS,Topp MS,Raposo J,Pavlov V,Ricci D,Chaturvedi S,Zhu E,van de Velde H,Enny C,Rizo A,Ferhanoglu B

    更新日期:2015-10-15 00:00:00

  • The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate.

    abstract::Imatinib mesylate, a competitive inhibitor of Abl tyrosine kinase, is highly effective for the early stages of chronic myelogenous leukemia (CML), but remissions induced in advanced-phase CML and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia tend to be relatively short-lived. Therefore, the searc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0305

    authors: Kuroda J,Kimura S,Segawa H,Kobayashi Y,Yoshikawa T,Urasaki Y,Ueda T,Enjo F,Tokuda H,Ottmann OG,Maekawa T

    更新日期:2003-09-15 00:00:00

  • Compartmentalization of cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils.

    abstract::The presence and physiologic role of cyclic GMP-dependent protein kinase (G-kinase) in human neutrophils was investigated by Western blot analysis and immunocytochemistry. Small quantities of G-kinase were found in the cytoskeletal-enriched fraction of neutrophil lysates as detected by Western blots using a polyclonal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pryzwansky KB,Wyatt TA,Nichols H,Lincoln TM

    更新日期:1990-08-01 00:00:00

  • Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

    abstract::We treated 109 patients with adult acute lymphoblastic leukemia (ALL) diagnosed by histochemical and immunologic techniques. Patients were excluded only for age greater than 50 years and Burkitt's leukemia. Treatment included a four-drug remission induction phase followed by alternating cycles of noncrossresistant che...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Linker CA,Levitt LJ,O'Donnell M,Forman SJ,Ries CA

    更新日期:1991-12-01 00:00:00

  • Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia.

    abstract::Reduced lymphopoiesis during aging contributes to declines in immunity, but little consideration has been given to its effect on the development of hematologic disease. This report demonstrates that age-related defects in lymphopoiesis underlie the myeloid dominance of adult leukemia. Using a murine model of chronic m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-069401

    authors: Signer RA,Montecino-Rodriguez E,Witte ON,McLaughlin J,Dorshkind K

    更新日期:2007-09-15 00:00:00

  • Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study.

    abstract::Hematopoietic regulation is a complex but dynamic process regulated by intercellular and intracellular interactions within the bone marrow (BM) microenvironment. Through neurokinin-1 (NK-1) and NK-2 receptors, peptides (eg, substance P [SP]) encoded by the preprotachykinin-I gene mediate distinct hematopoietic effects...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.9.2697

    authors: Joshi DD,Dang A,Yadav P,Qian J,Bandari PS,Chen K,Donnelly R,Castro T,Gascon P,Haider A,Rameshwar P

    更新日期:2001-11-01 00:00:00

  • Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies.

    abstract::Peripheral blood and bone marrow mononuclear cells from patients with refractory anemia (RA) or RA with sideroblasts (defined according to the revised French-American-British classification with less than 5% blast cells in the bone marrow) were analyzed using a panel of monoclonal antibodies directed against leukocyte...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hokland P,Kerndrup G,Griffin JD,Ellegaard J

    更新日期:1986-04-01 00:00:00

  • AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.

    abstract::Somatic hypermutation and class-switch recombination of the immunoglobulin (Ig) genes occur in germinal center (GC) B cells and are initiated through deamination of cytidine to uracil by activation-induced cytidine deaminase (AID). Resulting uracil-guanine mismatches are processed by uracil DNA glycosylase (UNG)-media...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-02-628164

    authors: Gu X,Booth CJ,Liu Z,Strout MP

    更新日期:2016-01-07 00:00:00

  • LXR as a novel antithrombotic target.

    abstract::Liver X receptors (LXRs) are transcription factors involved in the regulation of cholesterol homeostasis. LXR ligands have athero-protective properties independent of their effects on cholesterol metabolism. Platelets are involved in the initiation of atherosclerosis and despite being anucleate express nuclear recepto...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-306142

    authors: Spyridon M,Moraes LA,Jones CI,Sage T,Sasikumar P,Bucci G,Gibbins JM

    更新日期:2011-05-26 00:00:00

  • Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.

    abstract::Internal tandem duplication of the Fms-like tyrosine kinase-3 receptor (FLT3) internal tandem duplication (ITD) is found in 30% of acute myeloid leukemia (AML) and is associated with a poor outcome. In addition to tyrosine kinase inhibitors, therapeutic strategies that modulate the expression of FLT3-ITD are also prom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-05-646497

    authors: Larrue C,Saland E,Boutzen H,Vergez F,David M,Joffre C,Hospital MA,Tamburini J,Delabesse E,Manenti S,Sarry JE,Récher C

    更新日期:2016-02-18 00:00:00

  • The peritoneal micromilieu commits B cells to home to body cavities and the small intestine.

    abstract::The distinct combination of homing receptors such as selectins, chemokine receptors, and integrins directs the migration of lymphocytes throughout the body. Upon activation lymphocytes irreversibly switch their set of homing receptors, now guiding them to entirely different destinations. Here we report that exposure o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-12-064345

    authors: Berberich S,Förster R,Pabst O

    更新日期:2007-06-01 00:00:00

  • The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

    abstract::The functions of the alphaC domains of fibrinogen in clotting and fibrinolysis, which have long been enigmatic, were determined using recombinant fibrinogen truncated at Aalpha chain residue 251. Scanning electron microscopy and confocal microscopy revealed that the fibers of alpha251 clots were thinner and denser, wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-2150

    authors: Collet JP,Moen JL,Veklich YI,Gorkun OV,Lord ST,Montalescot G,Weisel JW

    更新日期:2005-12-01 00:00:00

  • Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT).

    abstract::De novo erythroleukemia (EL) is a rare disease. Reported median survival are poor and vary from 4 to 14 months. The value of hematopoietic stem cell transplantation (HSCT) for EL is unknown. This EBMT registry study reports on the largest series of patients with EL treated with HSCT in first complete remission-103 aut...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood.V100.9.3135

    authors: Fouillard L,Labopin M,Gorin NC,Polge E,Prentice HG,Meloni G,Reiffers J,Pigneux A,Willemze R,Schattenberg A,Sica S,Lagrange M,Fenneteau O,Perot C,Frassoni F,Acute Leukemia Working Party of the EBMT.

    更新日期:2002-11-01 00:00:00

  • Treatment of paroxysmal nocturnal hemoglobinuria.

    abstract::Patients with PNH may be treated with a number of known agents. As in all patients with a chronic disease, a regimen tolerable over a long period of time must be selected. Knowledge and anticipation of complications and their proper treatment are essential parts in the treatment. When these principals are used, many p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rosse WF

    更新日期:1982-07-01 00:00:00